---
title: Tumor-associated pain
date: '2024-01-11'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38206419/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240111170708&v=2.18.0
source: heidelberg[Affiliation]
description: Tumor-associated pain has a high prevalence and is still a challenging
  aspect of pain medicine. Treatment-related etiologies often coexist with pain caused
  by the oncological disease itself. For cancer pain as well, a pathophysiologically
  oriented analysis of nociceptive, nociplastic and neuropathic pain is advisable
  for planning a tailored treatment. The analgesic three-step ladder of the World
  Health Organization (WHO) should be customized in this context, incorporating antineuropathic
  ...
disable_comments: true
---
Tumor-associated pain has a high prevalence and is still a challenging aspect of pain medicine. Treatment-related etiologies often coexist with pain caused by the oncological disease itself. For cancer pain as well, a pathophysiologically oriented analysis of nociceptive, nociplastic and neuropathic pain is advisable for planning a tailored treatment. The analgesic three-step ladder of the World Health Organization (WHO) should be customized in this context, incorporating antineuropathic ...